Effects and Mechanism of Combination of Rhein and Danshensu in the Treatment of Chronic Kidney Disease

American Journal of Chinese Medicine

Volumn 43, Issue 7, 2015, Pages 1381-1400

  Guan, Yue ^a   Wu, Xiao Xiao ^a   Duan, Jia Lin ^a   Yin, Ying ^a   Guo, Chao ^a   Wei, Guo ^a   Wang, Yan Hua ^a   Zhu, Yan Rong ^a   Weng, Yan ^a   Xi, Miao Miao ^a   Wen, Ai Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Combination; Danshensu; Rhein

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; I KAPPA B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; RHEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; 3,4-DIHYDROXYPHENYLLACTIC ACID; ANTHRAQUINONE DERIVATIVE; AUTACOID; CELL ADHESION MOLECULE; CYTOKINE; DRUG COMBINATION; ENZYME INHIBITOR; LACTIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL VIABILITY; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY HOMOGENATE; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY PARENCHYMA; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; VASCULARIZATION; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; RENAL INSUFFICIENCY, CHRONIC; RHEUM; SALVIA MILTIORRHIZA;

ANIMALS; ANTHRAQUINONES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; DRUG COMBINATIONS; ENZYME INHIBITORS; HUMANS; INFLAMMATION MEDIATORS; LACTATES; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RENAL INSUFFICIENCY, CHRONIC; RHEUM; SALVIA MILTIORRHIZA;

EID: 84949728933     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X15500780     Document Type: Article

References (33)

1. Azuma, H., N. Tomita, Y. Kaneda, H. Koike, T. Ogihara, Y. Katsuoka and R. Morishita. Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther. 10: 415-425, 2003.
2. Chen, S., S. Zhou, B. Wu, Y. Zhao, X. Liu, Y. Liang, X. Shao, H. Holthöfer and H. Zou. Association between metabolically unhealthy overweight/obesity and chronic kidney disease: The role of inflammation. Diabetes Metab. 40: 423-430, 2014.
3. Cui, X., Y. Wang, N. Kokudo, D. Fang and W. Tang. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci. Trends 4: 39-47, 2010.
4. Dolkart, O., W. Khoury, E. Amar and A.A. Weinbroum. Pneumoperitoneum in the presence of acute and chronic kidney injury: An experimental model in rats. J. Urol. 192: 1266-1271, 2014.
5. Floege, J., C.E. Alpers, M.W. Burns, P. Pritzl, K. Gordon, W.G. Couser and R.J. Johnson. Glo-merular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab. Invest. 66: 485-497, 1992.
6. Fogo, A.B. Mechanisms of progression of chronic kidney disease. Pediatr. Nephrol. 22: 2011-2022, 2007.
7. Gadola, L., O. Noboa, M.N. Marquez, M.J. Rodriguez, N. Nin, J. Boggia, A. Ferreiro, S. García, V. Ortega, M.L. Musto, P. Ponte, P. Sesser, C. Pizarrosa, S. Ravaglio and A. Vallega. Calcium citrate ameliorates the progression of chronic renal injury. Kidney Int. 65: 1224-1230, 2004.
8. Guan, Y., Y. Yin, Y.R. Zhu, C. Guo, G. Wei, J.L. Duan, Y.H. Wang, D. Zhou, W. Quan, Y. Weng, M.M. Xi and A.D. Wen. Dissection of mechanisms of a Chinese medicinal formula: Danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro. Evid. Based Complement. Alternat. Med. 2013: 972370, 2013.
9. Guo, X.H., Z.H. Liu, C.S. Dai, H. Li, D. Liu and L.S. Li. Rhein inhibits renal tubular epithelial cell hypertrophy and extracellular matrix accumulation induced by transforming growth factor beta1. Acta Pharmacol. Sin. 22: 934-938, 2001.
10. He, D., L. Lee, J. Yang and X. Wang. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy. Biol. Pharm. Bull. 34: 1219-1226, 2011.
11. Jha, V., G. Garcia-Garcia, K. Iseki, Z. Li, S. Naicker, B. Plattner, R. Saran, A.Y. Wang and C.W. Yang. Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260-272, 2013.
12. Ji, Z.Q., C.W. Huang, C.J. Liang, W.W. Sun, B. Chen and P.R. Tang. Effects of rhein on activity of caspase-3 in kidney and cell apoptosis on the progression of renal injury in glomerulosclerosis. Zhonghua Yi Xue Za Zhi 85: 1836-1841, 2005.
13. Kisseleva, T. and D.A. Brenner. Mechanisms of fibrogenesis. Exp. Biol. Med. (Maywood) 233: 109-122, 2008.
14. Koike, K., S. Ueda, S. Yamagishi, H. Yasukawa, Y. Kaida, M. Yokoro, K. Fukami, A. Yoshimura and S. Okuda. Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction. Clin. Immunol. 150: 78-87, 2014.
15. Lee, L.K., T.W. Meyer, A.S. Pollock and D.H. Lovett. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96: 953-964, 1995.
16. Lian, Y., L. Xie, M. Chen and L. Chen. Effects of an astragalus polysaccharide and rhein combination on apoptosis in rats with chronic renal failure. Evid. Based Complement Alternat. Med. 2014: 271862, 2014.
17. Liu, H., W. Sun, Y.G. Wan, Y. Tu, B.Y. Yu and H. Hu. Regulatory mechanism of NF-κB signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 38: 4246-4251, 2013.
18. Lopez-Hernandez, F.J. and J.M. Lopez-Novoa. Role of TGF-beta in chronic kidney disease: An integration of tubular, glomerular and vascular effects. Cell Tissue Res. 347: 141-154, 2012.
19. Luo, J.A., Y.M. Peng, Y.C. Xia and Y. Lei. Therapeutic effects of Chinese drugs on early renal damage of rats caused by fish bile. Zhongguo Zhong Xi Yi Jie He Za Zhi 13: 98-9, 70, 1993.
20. Meng, X.M., A.C. Chung and H.Y. Lan. Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin. Sci. (London) 124: 243-254, 2013.
21. Miller, D.L., C. Dou, R.C. Wiggins, B.L. Wharram, M. Goyal and A.R. Williams. An in vivo rat model simulating imaging of human kidney by diagnostic ultrasound with gas-body contrast agent. Ultrasound Med. Biol. 33: 129-135, 2007.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 39: S1-266, 2002.
23. Ngai, H.H., W.H. Sit and J.M. Wan. The nephroprotective effects of the herbal medicine preparation, WH30, on the chemical-induced acute and chronic renal failure in rats. Am. J. Chin. Med. 33: 491-500, 2005.
24. Rodriguez-Barbero, A., F. Dorado, S. Velasco, A. Pandiella, B. Banas and J.M. Lopez-Novoa. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int. 70: 901-909, 2006.
25. Su, J., L.P. Yin, X. Zhang, B.B. Li, L. Liu and H. Li. Chronic allograft nephropathy in rats is improved by the intervention of rhein. Transplant Proc. 45: 2546-2552, 2013.
26. Vaziri, N.D., S.M. Liu, W.L. Lau, M. Khazaeli, S. Nazertehrani, S.H. Farzaneh, D.A. Kieffer, S.H. Adams and R.J. Martin. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS One 9: e114881, 2014.
27. Wang, J., Y.G. Wan, W. Sun, H.L. Zhang, P. Chen and J. Yao. Progress in Japanese herbal medicine in treatment of chronic kidney disease. Zhongguo Zhong Yao Za Zhi 33: 1348-1352, 2008.
28. Wang, W., X.R. Huang, A.G. Li, F. Liu, J.H. Li, L.D. Truong, X.J. Wang and H.Y. Lan. Signaling mechanism of TGF-β1 in prevention of renal inflammation: Role of Smad7. J. Am. Soc. Nephrol. 16: 1371-1383, 2005.
29. Wojcikowski, K., D.W. Johnson and G. Gobe. Herbs or natural substances as complementary therapies for chronic kidney disease: Ideas for future studies. J. Lab. Clin. Med. 147: 160-166, 2006.
30. Xiao, W., H.Z. Deng and Y. Ma. Summarization of the clinical and laboratory study on the rhubarb in treating chronic renal failure. Zhongguo Zhong Yao Za Zhi 27: 241-244, 262, 2002.
31. Zhao, G.R., H.M. Zhang, T.X. Ye, Z.J. Xiang, Y.J. Yuan, Z.X. Guo and L.B. Zhao. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol. 46: 73-81, 2008.
32. Zheng, J.M., J.M. Zhu, L.S. Li and Z.H. Liu. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br. J. Pharmacol. 153: 1456-1464, 2008.
33. Zhu, W. and X.M. Wang. Progress in study on mechanisms of rhubarb in treating chronic renal failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 471-475, 2005.